-->
Guardant Health soars 70% in first day of trading

Guardant Health soars 70% in first day of trading

Guardant Health CEO Helmy Eltoukhy told CNBC on Thursday the company's liquid biopsy, Guardant360, is a "big game changer" when it comes to the detection of cancer.

from Business News https://ift.tt/2NimKIh

Related Posts

0 Response to "Guardant Health soars 70% in first day of trading"

ads

ads 2

Iklan Tengah Artikel 2

ads 3